How Is Ketamine Tablet Different From IV Infusion?

Ketamine tablet and IV ketamine infusion use the same active drug, racemic ketamine hydrochloride, but the route of administration changes how much of the drug reaches the brain, how fast it works, how long it lasts, and how it feels. IV infusion delivers ketamine directly into a vein, so essentially all of it reaches circulation almost immediately. A ketamine tablet is swallowed, passes through the liver before reaching the bloodstream, and only 10-25% of the dose reaches circulation as unchanged ketamine, with most of the rest converted to the metabolite norketamine. That single difference, how is ketamine tablet different from IV infusion, explains most of the practical gaps between the two: onset speed, intensity, cost, and where each fits in a treatment plan.

A ketamine tablet is a compounded or prescribed oral dose of ketamine hydrochloride that a patient swallows or dissolves, most often used for at-home maintenance therapy. IV ketamine infusion is a clinic-based treatment in which ketamine is administered directly into a vein over roughly 40 minutes to an hour, most often used to induce a rapid antidepressant response in an acute episode.

Same Drug, Different Path Into the Body

IV ketamine is injected directly into a vein, so the full dose enters systemic circulation immediately with no digestion and no first-pass liver metabolism. Peak plasma levels are reached within minutes and are far higher than any oral dose produces.

A ketamine tablet takes a longer route. After swallowing, the drug is absorbed through the stomach and small intestine, then passes through the liver before reaching the bloodstream. According to StatPearls, oral ketamine undergoes extensive first-pass hepatic metabolism, converting roughly 75-90% of the dose into metabolites, primarily norketamine, before it ever reaches systemic circulation. Only about 10-25% of an oral dose reaches the bloodstream as unchanged ketamine. Norketamine is itself pharmacologically active and shapes the oral experience in ways IV dosing does not. For more detail, see our guides on norketamine's role in ketamine tablet effects and the underlying bioavailability research.

Onset, Peak Effect, and Duration

IV effects begin within minutes. At the standard clinical dose of 0.5 mg/kg over 40 minutes, most patients experience significant dissociation by 10-15 minutes into the infusion, with peak plasma levels during or immediately after dosing. Plasma levels then fall quickly, and most patients are close to baseline within 1-2 hours after the infusion ends.

A ketamine tablet takes effect more gradually, generally 30-60 minutes after swallowing. Troches dissolved in the mouth absorb somewhat faster, in 15-30 minutes, because some ketamine bypasses first-pass metabolism through the oral mucosa. Peak plasma levels occur 1-2 hours after dosing, and effects typically last 3-5 hours, longer than IV, due to slower absorption and norketamine's extended half-life.

For a patient in acute psychiatric crisis who needs the fastest possible relief, IV produces measurable effects sooner. For routine, ongoing therapy, the slower oral onset is generally considered clinically acceptable.

Intensity and Antidepressant Effect

IV ketamine tends to produce a more intense, immersive dissociative experience, described by some patients as dream-like. Because peak levels arrive quickly and at higher concentration, significant dissociation is close to universal at the standard 0.5 mg/kg dose. The experience is also shorter.

A ketamine tablet produces a gentler, more gradual effect at typical therapeutic doses, mild to moderate dissociation rather than a profound alteration in perception. Many patients can still hold a conversation, though judgment and driving remain impaired for hours afterward. Some anxious patients find the oral route more manageable specifically because it is less intense.

Both routes work through ketamine's action on NMDA glutamate receptors, and both produce measurable antidepressant effects. Pharmacokinetic data cataloged by PubChem, combined with the clinical literature, generally supports IV producing a larger, more reliable antidepressant effect per session, with improvement often emerging within hours. Oral dosing tends to produce a somewhat smaller effect per session, with improvement emerging over 24-72 hours, but it can be sustained more easily through ongoing maintenance dosing. For severe, acute depression, IV currently has the stronger evidence base; for maintenance therapy, oral dosing is more practical, and available evidence suggests comparable outcomes with appropriate dosing. See our review of long-term outcomes data for more detail.

Cost, Access, and Clinical Monitoring

IV infusions typically cost $400-$800 each at US clinics, with a standard six-infusion induction course running $2,400-$4,800. Insurance rarely covers IV ketamine for psychiatric indications. A ketamine tablet is far less expensive, generally $8-$30 per dose, with monthly maintenance protocols running $200-$600, or $130-$400 per month when bundled through telehealth. Coverage gaps exist for both routes; see Healthcare.gov for general guidance on out-of-pocket cost terms, and our breakdown of the oral ketamine insurance coverage gap for specifics.

IV requires an infusion clinic, travel, and scheduled appointments, which limits access in rural areas. A compounded ketamine tablet can be prescribed through telehealth and shipped to a patient's home, making it more accessible but also shifting monitoring responsibility onto the patient. IV dosing happens under nursing supervision with blood pressure and heart rate tracked throughout the infusion. Oral dosing is typically self-administered at home, with monitoring limited to self-report between prescriber visits, so appropriate patient selection matters.

Which Route Fits Your Situation

IV ketamine tends to be the better choice for:

• An acute, severe depressive episode requiring a rapid response
• High suicide risk requiring a rapid anti-suicidal effect
• Situations where strong acute antidepressant induction is the immediate goal
• Patients with reasonable access to an infusion clinic

A ketamine tablet tends to be the better choice for:

• Maintenance therapy after an initial IV induction course
• Patients facing geographic or financial barriers to IV access
• Protocols requiring daily or near-daily dosing, which is impractical with IV
• Patients who find the intensity of IV difficult to tolerate
• Clinically appropriate home-based treatment
• Chronic pain conditions requiring continuous dosing

The most common clinical pattern combines both: IV ketamine for acute induction over the first 2-4 weeks, followed by a ketamine tablet for ongoing maintenance. This pairs IV's reliable acute effect with the practicality of oral dosing over time.

Sources

This overview draws on the following references:

• StatPearls: Ketamine, a clinical reference on ketamine pharmacology, mechanisms of action, and therapeutic applications.
• PubChem: Ketamine Compound Summary, the NCBI chemical database entry with molecular data and pharmacokinetics.
• MedlinePlus, National Library of Medicine consumer drug information.
• Healthcare.gov, federal marketplace resource on out-of-pocket healthcare costs.